IL197920A0 - Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods - Google Patents

Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods

Info

Publication number
IL197920A0
IL197920A0 IL197920A IL19792009A IL197920A0 IL 197920 A0 IL197920 A0 IL 197920A0 IL 197920 A IL197920 A IL 197920A IL 19792009 A IL19792009 A IL 19792009A IL 197920 A0 IL197920 A0 IL 197920A0
Authority
IL
Israel
Prior art keywords
polypeptides
inflammatory
enhanced anti
cytotoxic properties
decreased cytotoxic
Prior art date
Application number
IL197920A
Other languages
English (en)
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/041791 external-priority patent/WO2007055916A2/en
Priority claimed from PCT/US2007/008396 external-priority patent/WO2007117505A2/en
Priority claimed from PCT/US2007/072771 external-priority patent/WO2008057634A2/en
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of IL197920A0 publication Critical patent/IL197920A0/en

Links

IL197920A 2006-10-27 2009-04-05 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods IL197920A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2006/041791 WO2007055916A2 (en) 2005-11-07 2006-10-27 Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
PCT/US2007/008396 WO2007117505A2 (en) 2006-04-05 2007-04-03 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
PCT/US2007/072771 WO2008057634A2 (en) 2006-10-26 2007-07-03 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods

Publications (1)

Publication Number Publication Date
IL197920A0 true IL197920A0 (en) 2011-08-01

Family

ID=40792829

Family Applications (1)

Application Number Title Priority Date Filing Date
IL197920A IL197920A0 (en) 2006-10-27 2009-04-05 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods

Country Status (3)

Country Link
JP (1) JP2010512306A (https=)
CA (1) CA2666308C (https=)
IL (1) IL197920A0 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR085302A1 (es) * 2011-02-24 2013-09-18 Sanofi Sa Metodo de produccion de anticuerpos sialilados
UY34317A (es) 2011-09-12 2013-02-28 Genzyme Corp Anticuerpo antireceptor de célula T (alfa)/ß
US9790268B2 (en) 2012-09-12 2017-10-17 Genzyme Corporation Fc containing polypeptides with altered glycosylation and reduced effector function
US9701753B2 (en) 2013-03-11 2017-07-11 Genzyme Corporation Hyperglycosylated binding polypeptides
WO2015143091A1 (en) 2014-03-19 2015-09-24 Genzyme Corporation Site-specific glycoengineering of targeting moieties
CN120192414A (zh) 2019-04-03 2025-06-24 建新公司 具有降低的断裂的抗αβTCR结合多肽
KR102549282B1 (ko) * 2019-11-18 2023-06-30 건국대학교 산학협력단 시알산화된 면역글로불린을 유효성분으로 포함하는 염증성 질환의 치료용 조성물
CN116705170A (zh) * 2023-05-08 2023-09-05 宁波市医疗中心李惠利医院 基于maldi-tof ms联合lstm的大肠埃希菌菌株水平鉴定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001507215A (ja) * 1997-01-16 2001-06-05 サイテル コーポレイション 組換え糖タンパク質のインビトロでの実用的なシアリル化
HK1048138B (zh) * 1999-04-15 2009-06-12 荷兰克鲁塞尔公司 用编码腺病毒e1蛋白的序列在人体细胞中生产重组蛋白
CA2424977C (en) * 2000-10-06 2008-03-18 Kyowa Hakko Kogyo Co., Ltd. Process for purifying antibody

Also Published As

Publication number Publication date
JP2010512306A (ja) 2010-04-22
CA2666308C (en) 2014-09-23
CA2666308A1 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
IL194526A0 (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
IL206029A0 (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
IL237314A (en) Insulin polypeptides are modified and their uses
IL185563A0 (en) Gip analog and hybrid polypeptides with selectable properties
EP2089480A4 (en) ANTIMICROBIAL MATERIALS AND ANTIMICROBIAL COATINGS
IL193198A0 (en) Long-actine polypeptides and methods of producing and administering same
IL194751A0 (en) Drugs and uses
PL2064327T3 (pl) Dbait i ich zastosowania
ZA200902161B (en) Antiobodies and immunoconjugates and uses therefor
ZA200904061B (en) Fuel composition and its use
ZA201002802B (en) Functionalised materials and uses thereof
IL197920A0 (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
ZA200903906B (en) Carboranylporphyrins and uses thereof
SI2068909T1 (sl) Modificirani fgf-21 polipeptidi in njihova uporaba
IL195525A0 (en) Replikin peptides and uses thereof
ZA200904583B (en) Dual composition with warming and analgesic effects
GB0621513D0 (en) Novel polypeptides and uses thereof
EP1977996A4 (en) PHOSPHATE METAL-CONTAINING COMPLEX AND THIS CONTAINING SEALED MATERIAL
GB0607798D0 (en) Novel polypeptides and use thereof
SI2032708T1 (sl) Rekombinantni novirabdovirusi in njihove uporabe
HK1135408A (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
HK1148933A (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
GB0701295D0 (en) Z-stilbenes derivatives and the pharmaceutical composition thereof
GB0907108D0 (en) Mutants and uses therefor
IL192800A0 (en) Fgf2-binding peptides and uses thereof